|
**Overview**: **Pollution Risk Check Basic Profile****Introduction**: The Pollution Risk Check Basic Profile is a diagnostic tool designed for basic pollution health screening using serum and whole blood samples. Associated with conditions like heavy metal poisoning and respiratory irritation, these disorders present with fatigue, respiratory issues, and severe complications if untreated, particularly in individuals with suspected environmental exposure. Per the 2023 Biochemistry, Hematology, and Clinical Pathology guidelines, the test employs biochemistry, hematology, and clinical pathology with spectrophotometry and automated cell counter technology, delivering detailed parameter analysis over 1-2 days with high sensitivity and specificity, making it a valuable tool for environmental exposure screening in clinical settings. This diagnostic falls under environmental exposure screening and targets individuals with suspected pollution-related disorders, addressing the challenge of accurate parameter assessment to guide treatment. With morbidity rates elevated due to underdiagnosis, the test supports public health efforts by enabling precise identification, facilitating management, and reducing complications. Its dual-sample approach ensures reliable detection.**Other Names**: Poll Risk Basic Pfl.**FDA Status**: FDA approved, CLIA certified for biochemistry, hematology, and clinical pathology, compliant with 2025 standards.**Historical Milestone**: Introduced in the 2000s by environmental health labs, this test advanced basic pollution risk assessment.**Purpose**: The test screens for 22 parameters including hemoglobin to guide pollution risk assessment, assess environmental toxin levels and health parameters, and inform treatment and prevention strategies.**Test Parameters**: 1. Hemoglobin, 2. WBC Count, 3. Platelet Count, 4. ESR, 5. CRP, 6. Total Bilirubin, 7. AST, 8. ALT, 9. ALP, 10. Creatinine, 11. Urea, 12. Lead, 13. Mercury, 14. Cadmium, 15. Total IgE, 16. Vitamin D, 17. Calcium, 18. Magnesium, 19. Total Cholesterol, 20. HDL, 21. LDL, 22. Triglycerides.**Pretest Condition**: Fasting 10-12 hours required; patients should report fatigue, respiratory issues, or recent environmental exposure symptoms.**Specimen**: 3 mL serum in 1 SST, 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours (Serum), 48 hours (Blood) with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days (Serum, Blood) at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months (Serum) at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on fatigue, respiratory issues, prior exposure reactions, or family history of environmental illnesses, as well as any recent trauma or treatments.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated pollution exposure including organ damage, benefits of early detection, and minimal discomfort from sample collection.**Procedural Considerations**: The test involves sample processing using spectrophotometry and automated cell counter and interpret results within 1-2 days using provided controls.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, cross-contamination with other samples, or recent detoxification therapy can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible pollution-related disorders, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: General practitioners or specialists in environmental medicine should be consulted for case management, treatment planning, and coordination with health programs.**Additional Supporting Tests**: Heavy metal testing or imaging for confirmation.**Test Limitations**: The test may produce false negatives in early exposure stages or false positives in sample degradation, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Biochemistry, Hematology, and Clinical Pathology Guidelines 2023, Journal of Environmental Health 2024, Chemistry 2025. |
